Article

Blood-based transcriptomic biomarkers are predictive of neurodegeneration rather than Alzheimer’s disease

2023-09-17

Abstract excerpt

Alzheimer’s disease (AD) is a growing global health crisis, affecting millions and incurring substantial economic costs. However, clinical diagnosis remains challenging, with misdiagnoses and underdiagnoses prevalent. There is an increased focus on putative, blood-based biomarkers that may be useful for the diagnosis, as well as early detection, of AD. In the present study, we used an unbiased combination of machi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 752ae24d-39a8-593c-a9dc-0d7241ad6b1a
DOI: 10.1101/2023.09.15.23295651

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Blood-based transcriptomic biomarkers are predictive of neurodegeneration rather than Alzheimer’s diseaseDOI 10.1101/2023.09.15.23295651Read

Blood-Based RNA Biomarkers and Machine Learning Approaches for Alzheimer’s DiseaseSemantic proximity Read

Blood RNA transcripts reveal similar and differential alterations in fundamental cellular processes in Alzheimer's disease and other neurodegenerative diseasesSemantic proximity Read

An RNA biomarker panel for the diagnosis of Alzheimer’s disease from whole bloodSemantic proximity Read

Toward an Alzheimer's disease diagnosis via high‐resolution blood gene expressionSemantic proximity Read

Systematic Analysis and Biomarker Study for Alzheimer’s DiseaseSemantic proximity Read

Identification of common molecular biomarker signatures in blood and brain of Alzheimer’s diseaseSemantic proximity Read

Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratificationSemantic proximity Read

A diagnostic plasma omics-biomarker for Alzheimer’s disease informed by microglial single-cell transcriptomics: A pilot studySemantic proximity Read

Validation of AclarusDx™, a Blood-Based Transcriptomic Signature for the Diagnosis of Alzheimer's DiseaseSemantic proximity Read

A transcriptome-wide association study identifies novel blood-based gene biomarker candidates for Alzheimer's disease risk.Semantic proximity Read

Meta‐Analysis of Transcriptomic Studies of Blood and Six Brain Regions Identifies a Consensus of 15 Cross‐Tissue Mechanisms in Alzheimer's Disease and Suggests an Origin of Cross‐Study HeterogeneitySemantic proximity Read

Exploratory Single-Cell RNA Sequencing of Peripheral Blood Identifies Candidate Signatures Associated with Alzheimer’s DiseaseSemantic proximity Read